Course Outcome
CO1 To understand patterns of inheritance and laws of heredity at molecular levels
CO2 To understand about chromosomes and their transmission during cell divisions, genetic linkage and mapping in Eukaryotes, variations in chromosome structure and number, and chromosome organization and molecular structure
CO3 To comprehend various modes of epigenetic regulation on gene expression in
Eukaryotes and roles of noncoding RNA in gene regulation
CO4 To learn about genetic principles underlying medical, immune and developmental aspects
CO5 To gather knowledge of complex and quantitative traits, polygenic
Inheritance, population genetics, phylogenic trees and molecular evolution
Program Outcomes (PO) (As given by NBA and ABET)
PO1: Bioscience Knowledge
PO2: Problem Analysis
PO3: Design/Development of Solutions
PO4: Conduct Investigations of complex problems
PO5: Modern tools usage
PO6: Bioscientist and Society
PO7: Environment and Sustainability
PO8: Ethics
PO9: Individual & Team work
PO10: Communication
PO11: Project management & Finance
PO12: Lifelong learning
CO–PO Mapping Table:
COs
|
PO1
|
PO2
|
PO3
|
PO4
|
PO5
|
PO6
|
PO7
|
PO8
|
PO9
|
PO10
|
PO11
|
PO12
|
CO1
|
3
|
2
|
–
|
2
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
2
|
CO2
|
3
|
3
|
–
|
3
|
2
|
–
|
–
|
–
|
–
|
–
|
–
|
2
|
CO3
|
3
|
2
|
–
|
2
|
2
|
–
|
–
|
–
|
–
|
–
|
–
|
2
|
CO4
|
3
|
3
|
–
|
3
|
–
|
2
|
–
|
–
|
–
|
–
|
–
|
2
|
CO5
|
3
|
3
|
–
|
3
|
2
|
–
|
1
|
–
|
–
|
–
|
–
|
2
|
0 – No affinity; 1 – low affinity; 2 – Medium affinity; 3 – High affinity
Program Specific Outcomes (PSO):
PSO1. Apply fundamental molecular biology principles to interpret clinical genomic data.
PSO2. Use molecular techniques (e.g., PCR, RT-PCR, sequencing) to detect genetic mutations and biomarkers.
PSO3. Analyze genotype-phenotype correlations in inherited and acquired disorders.
PSO4. Identify pathogenic variants from NGS data and interpret their clinical relevance.
PSO5. Correlate molecular pathways with disease mechanisms and therapeutic targets.
PSO6. Develop and validate diagnostic assays based on molecular biology principles.
PSO7. Utilize molecular biology to support pharmacogenomic profiling and therapy optimization.
PSO8. Integrate multi-omic data (genomic, transcriptomic, epigenomic) for personalized health solutions.
PSO9. Apply molecular knowledge to cancer genomics, infectious diseases, and rare genetic disorders.
PSO10. Translate molecular discoveries into clinical interventions through evidence-based practice.
CO–PSO Mapping Table:
COs
|
PSO1
|
PSO2
|
PSO3
|
PSO4
|
PSO5
|
PSO6
|
PSO7
|
PSO8
|
PSO9
|
PSO10
|
CO1
|
3
|
–
|
3
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
CO2
|
3
|
–
|
3
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
CO3
|
2
|
–
|
–
|
–
|
3
|
–
|
–
|
2
|
–
|
–
|
CO4
|
3
|
2
|
3
|
–
|
3
|
–
|
2
|
–
|
2
|
2
|
CO5
|
3
|
–
|
3
|
–
|
3
|
–
|
–
|
–
|
–
|
2
|